Trial Profile
The predictors of Brovana (Arformoterol) use in patients with Chronic Obstructive Pulmonary Disease: A Retrospective Cohort study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 May 2020
Price :
$35
*
At a glance
- Drugs Arformoterol (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 24 May 2017 Results presented at the 22nd Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research
- 22 May 2017 New trial record